These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 1288538)
21. Understanding the fundamentals of perfluorocarbons and perfluorocarbon emulsions relevant to in vivo oxygen delivery. Riess JG Artif Cells Blood Substit Immobil Biotechnol; 2005; 33(1):47-63. PubMed ID: 15768565 [TBL] [Abstract][Full Text] [Related]
22. [A comparative study of the effects of hemodilution with dextran and fluorocarbon emulsion on the changes in blood viscosity and collateral flow during myocardial ischemia]. Ma XL; Zhao RR; Zang YM; Wang FZ Yao Xue Xue Bao; 1987 Sep; 22(9):641-4. PubMed ID: 2451396 [No Abstract] [Full Text] [Related]
23. Oxygen delivery from fluorocarbon emulsions--aspects of convective and diffusive transport. Faithfull NS Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):797-804. PubMed ID: 1391514 [TBL] [Abstract][Full Text] [Related]
24. A perfluorochemical emulsion as an oxygen carrier. Yokoyama K; Suyama T; Okamoto H; Watanabe M; Ohyanagi H; Saitoh Y Artif Organs; 1984 Feb; 8(1):34-40. PubMed ID: 6703924 [TBL] [Abstract][Full Text] [Related]
25. The use of fluorocarbon emulsions in cancer radiotherapy. Guichard M Radiother Oncol; 1991; 20 Suppl 1():59-64. PubMed ID: 2020771 [TBL] [Abstract][Full Text] [Related]
26. Enhancement by perflusion emulsion (Oxygent) and carbogen breathing of the tumor growth delay of the FSaIIC fibrosarcoma after treatment with antitumor alkylating agents. Holden SA; Teicher BA; Ha C; Ara G; Herman TS Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):895-8. PubMed ID: 1391529 [TBL] [Abstract][Full Text] [Related]
27. Prolonged shelf stability and biocompatibility of a concentrated injectable fluorocarbon emulsion. Follana R; Klein D; Krafft MP; Long DM; Long CD; Ni Y; Riess JG; Valla A Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):1059-61. PubMed ID: 1391426 [TBL] [Abstract][Full Text] [Related]
28. Use of Oxygent, a perfluorochemical-based oxygen carrier, as an alternative to intraoperative blood transfusion. Keipert PE Artif Cells Blood Substit Immobil Biotechnol; 1995; 23(3):381-94. PubMed ID: 7493059 [TBL] [Abstract][Full Text] [Related]
29. [Current research on oxygen carriers for transfusion: hemoglobin solutions and fluorocarbon emulsions]. Labrude P Ann Pharm Fr; 1992; 50(5-6):250-66. PubMed ID: 1307671 [TBL] [Abstract][Full Text] [Related]
30. A new type of fluorocarbon liquid oxygenator. Mottaghy K; Mendler N; Schmid-Schönbein H; Schröck R; Sebening F Eur Surg Res; 1976; 8(3):196-203. PubMed ID: 7460 [TBL] [Abstract][Full Text] [Related]
32. Recent studies on perfluorochemical (PFC) emulsion as an oxygen carrier in Japan. Mitsuno T; Ohyanagi H; Yokoyama K; Suyama T Biomater Artif Cells Artif Organs; 1988; 16(1-3):365-73. PubMed ID: 3052644 [TBL] [Abstract][Full Text] [Related]
33. Current status of injectable oxygen carriers. Zuck TF; Riess JG Crit Rev Clin Lab Sci; 1994; 31(4):295-324. PubMed ID: 7888075 [TBL] [Abstract][Full Text] [Related]
34. Biodistribution of mixed fluorocarbon-hydrocarbon dowel molecules used as stabilizers of fluorocarbon emulsions: a quantitative study by fluorine nuclear magnetic resonance (NMR). Zarif L; Postel M; Septe B; Trevino L; Riess JG; Mahé AM; Follana R Pharm Res; 1994 Jan; 11(1):122-7. PubMed ID: 8140043 [TBL] [Abstract][Full Text] [Related]
35. Biodistribution and excretion of a mixed fluorocarbon-hydrocarbon "dowel" emulsion as determined by 19F NMR. Zarif L; Postel M; Trevino L; Riess JG; Valla A; Follana R Artif Cells Blood Substit Immobil Biotechnol; 1994; 22(4):1193-8. PubMed ID: 7849922 [TBL] [Abstract][Full Text] [Related]
36. A comparison study of rat pancreas preservation using perfluorochemical and fluorocarbon-emulsion as preservation medium. Urushihara T; Sumimoto K; Ikeda M; Yamanaka K; Hong HQ; Ito H; Fukuda Y; Dohi K Biomater Artif Cells Immobilization Biotechnol; 1992; 20(2-4):933-7. PubMed ID: 1391537 [TBL] [Abstract][Full Text] [Related]
37. Elaboration of fluorocarbon emulsions with improved oxygen-carrying capabilities. Riess JG; Krafft MP Adv Exp Med Biol; 1992; 317():465-72. PubMed ID: 1288158 [No Abstract] [Full Text] [Related]
38. Red cell substitutes: an update. Gould SA; Sehgal LR; Rosen AL; Sehgal HL; Moss GS Ann Emerg Med; 1985 Aug; 14(8):798-803. PubMed ID: 4025972 [TBL] [Abstract][Full Text] [Related]
39. [Toward a second generation of fluorocarbon emulsions. Methodologies: synthesis of fluorocarbons, formulation, preparation and control of emulsions]. Leblanc M Rev Fr Transfus Immunohematol; 1986 Dec; 29(6):465-83. PubMed ID: 3296111 [TBL] [Abstract][Full Text] [Related]
40. Gas embolism due to intravenous FC 80 liquid fluorocarbon. Sass DJ; Van Dyke RA; Wood EH; Johnson SA; Didisheim P J Appl Physiol; 1976 May; 40(5):745-51. PubMed ID: 931904 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]